Skip to main content
Medicine logoLink to Medicine
. 2017 Jan 20;96(3):e6039. doi: 10.1097/MD.0000000000006039

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction

PMCID: PMC5279117

The publisher has requested that the article “Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study”[1] be retracted. After publication, a reader brought to our attention inconsistencies in the methodology of the paper. The authors of the paper agreed that there were unforeseen inconsistencies in the data and the results were unreliable.

Reference

  • [1].Wei P, Yang J-W, Lu H-W, et al. Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study. Medicine. 2016. 95:e5116. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES